Industry Portals
Biotechnical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
![pexels-cottonbro-3944377](https://www.youngandpartners.com/wp/wp/wp-content/uploads/2021/02/pexels-cottonbro-3944377-scaled.jpg)
Chemical M&A strength in 2013 expected to continue (Chemical Week March 3, 2014 issue)
Chemical Week interviews Peter Young of Young & Partners about M&A in 2013 and 2014
Young & Partner Article – Positive M&A to Continue in 2014 (ICIS Chemical Business Feb 24, 2014 issue)
Young & Partners' view of 2013 (M&A, financial and business) and the outlook for 2014
Dow Chemical Reports a Profit – Wall Street Journal (January 29, 2014)
Young & Partners comments on shareholder activist's premise about Dow Chemical
ICIS News – Activist premise on Dow spin false (January 27, 2014)
Young & Partners disagrees with shareholder activist premise about Dow Chemical
Young & Partners 2013 Pharma Executive Summit: Fred Hassan Keynote Speech: Winning In the Current Environment
Keynote Speech by Fred Hassan, Managing Director, Warburg Pincus, and Former CEO of Schering-Plough, on "Winning In The Current Environment"
Young & Partners 2013 Pharma Executive Summit Fred Hassan Fireside Chat
Peter Young, CEO of Young & Partners, conducts fireside chat with Fred Hassan
Pharma and Biotech Financial Trends: Every Which Way (Young & Partners article written for the Pharma Exec Dec 2013 Issue)
Article summarizing the latest business, M&A and financial developments in Biopharma
Young & Partners 2013 Chemical Conference: Cal Dooley, CEO of the American Chemistry Council, Keynote Speech: The Current and Future Impact of Shale Gas on the Global Chemical Industry
Keynote speech by the CEO of the American Chemistry Council
Young & Partners 2013 Chemical Conference – Cal Dooley, CEO of the American Chemistry Council, Fireside Chat
Peter Young of Young & Partners conducts a fireside chat with the CEO of the American Chemistry Council
Activist Investors Target Chemicals (Young & Partners article in ICIS Oct. 1 – 13, 2013)
Perspectives on what these activists try to do and how should management react?
Chemical M&A Rebound Continues (Young & Partners article in ICIS Sept 30 – Oct 6, 2013)
Young & Partners describes the factors driving the ongoing rebound
Chemical M&A Market Revives (Young & Partners article in ICIS July 15 – 28, 2013)
Young & Partners article about what is driving the current chemical M&A revival
Sunny Outlook for Chemical Financing (Young & Partners article in ICIS Feb. 25 – March 3, 2013)
Overall chemical industry's debt and equity financing activity has been positive
Banker – M&A down in 2012, But Improving (Chemical Week Feb. 18, 2013 Issue)
Young & Partners' view of chemical industry M&A in 2012 and outlook for 2013
Chemical M&A Market Down But Not Out (Young & Partners article in ICIS Feb 11-17, 2013)
Unique insights about what happened last year and the positive outlook ahead
Breaking Waves – Turbulent Times for the Biopharma Business (Young & Partners Article in Pharma Exec Nov 2012 Issue)
Turbulence and Uncertainties Driving Pharma and Biotech M&A and Financial Environment